期刊文献+

“少阳主骨”理论考辨 被引量:35

Study on the theory of "Shaoyang Meridians being in charge of the bone"
下载PDF
导出
摘要 发掘和探讨湮没已久的《内经》"少阳主骨"之说。引证《内经》和历史上知名注家的论述和注释,对其内容和含义进行系统的考辨反思。结果表明"少阳主骨"学说有可能在世界上最早认识到关于骨质疏松的全身性骨骼病症,并发现体表足少阳可以自身调控骨强度的生理和病理变化,对以骨痛和骨折为主要临床表现的骨质疏松症有治疗作用。 to explore the theory of "Shaoyang Meridians being in charge of the bone" in Huangdi's Internal Classic, which has been buried for long time. With citation of Huangdi's Internal Classic and exposition of famous experts, speculate on the contents and meanings systematically. Results indicate that the theory of "Shaoyang Meridians being in charge of the bone" possibly first in the world recognizes osteoporosis being a general bony disease, and articulates that the Foot-Shaoyang Meradians can modulate bony strength under physiological and pathological conditions, and treat osteoporosis which mainly manifests as ostealgia and easy fracture.
出处 《中国针灸》 CAS CSCD 北大核心 2008年第6期469-471,共3页 Chinese Acupuncture & Moxibustion
基金 国家中医药管理局专项课题项目:06-07JP40
关键词 《内经》 肾(中医)/中医病机 少阳经 骨疾病/中医病机 Neijing Kidney (TCM)/pathog (TCM) Shaoyang Meridians Bone Diseases pathog (TCM)
  • 相关文献

参考文献7

  • 1张隐庵.灵枢集注[M].上海:上海卫生出版社,1957:93.
  • 2杨上善 肖延平.黄帝内经太素[M].北京:人民卫生出版社,1965.81.
  • 3王冰.黄帝内经素问[M].沈阳:辽宁科学技术出版社,1997.11-12
  • 4马莳.黄帝内经灵枢注证发微[M].北京:北京科学技术出版社,1998:38.
  • 5张景岳.类经[M].北京:人民卫生出版社,1965.332.
  • 6National Institutes of Health, USA. Osteoporosis prevention, diagnosis and therapy [J ]. JAMA, 2001,285 (6) :785-795.
  • 7夏维波.骨重建在维持骨强度中的意义[J].中华医学杂志,2006,86(6):363-365. 被引量:13

二级参考文献11

  • 1NIH consensus development panel on osteoporosis prevention,diagnosis,and therapy.Osteoporosis prevention,diagnosis,and therapy.JAMA,2001,285:785-795.
  • 2Watts NB.Bone quality:getting closer to a definition.J Bone Miner Res,2002,17:1148-1150.
  • 3Cummings SR,Karpf DB,Harris F,et al.Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs.Am J Med,2002,112:281-289.
  • 4Turner CH.Biomechanics of bone:determinants of skeletal fragility and bone quality.Osteoporos Int,2002,13:97-104.
  • 5Garnero P,Malmann D,Munoz F,et al.Long-term variability of bone markers of bone turnover in postmenopausal women and implicalions for their clinical utility.J Bone Miner Res,2002,17(Suppl 1) S299.
  • 6Eastell R,Barton I,Hannon RA,et al.Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.J Bone Miner Res,2003,18:1051-1056.
  • 7Delmas PD.How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis? Bone,2000,27:1-3.
  • 8Susan L,Greenspa N,Neil M,et al.Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate,hormone replacement therapy,or combination therapy:a three-year,double-blind,placebo-controlled,randomized clinical trial.J Clin Endo Metab,90:2762-2767.
  • 9夏维波,孟迅吾,胡莹莹,刘怀成,秦明伟,余卫,邢小平,田均平,周学瀛.阿伦膦酸钠防治原发性骨质疏松症的疗效观察[J].中国实用内科杂志,2000,20(4):214-216. 被引量:1
  • 10胡莹莹,夏维波,刘怀成,孟迅吾,周学瀛,邢小平.去卵巢和抗骨质疏松干预后大鼠尿脱氧吡啶啉的变化[J].中国医学科学院学报,2003,25(3):271-274. 被引量:2

共引文献74

同被引文献336

引证文献35

二级引证文献137

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部